Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
Condition(s):Leukemia; Non-Hodgkin’s Lymphoma; NHLLast Updated:August 14, 2007Unknown status
Hide Studies Not Open or Pending
Condition(s):Leukemia; Non-Hodgkin’s Lymphoma; NHLLast Updated:August 14, 2007Unknown status
Condition(s):Leukemia; Hairy Cell Leukemia; HCLLast Updated:April 18, 2007Unknown status
Condition(s):LeukemiaLast Updated:April 17, 2007Unknown status
Condition(s):Leukemia, Lymphoma, Chronic Lymphocytic; Leukemia, Prolymphocytic Leukemia, Small; Lymphocytic Lymphoma, Moxetumomab PasudotoxLast Updated:July 6, 2017Terminated
Condition(s):Hairy Cell LeukemiaLast Updated:April 2, 2019Completed
Condition(s):Leukemia; LymphomaLast Updated:December 28, 2007Suspended
Condition(s):Systemic Sclerosis; SclerodermaLast Updated:March 5, 2015Completed
Condition(s):AsthmaLast Updated:January 31, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.